Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00212342
Status:
COMPLETED
Last Update Posted:
2010-09-08
First Post:
2005-09-13
Brief Title:
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea
Sponsor:
Nobelpharma
Organization:
Nobelpharma
Study Overview
Official Title:
Phase 3Placebo ControlledRandomizedDouble-BlindedNSAID-Add-onClinical Trial of Mono-phase Low Dose Oral Contraceptive Pill for Treatment of Dysmenorrhea Associated With Endometriosis
Status:
COMPLETED
Status Verified Date:
2010-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether combination oral contraceptive pill of Norethindrone Ethinyl estradiol is effective in the treatment of dysmenorrhea associated with endometriosis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None